Monoclonal Antibody-Mediated CD200 Receptor Signaling Suppresses Macrophage Activation and Tissue Damage in Experimental Autoimmune Uveoretinitis
- 31 August 2007
- journal article
- Published by Elsevier BV in The American Journal of Pathology
- Vol. 171 (2), 580-588
- https://doi.org/10.2353/ajpath.2007.070272
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Retinal microenvironment controls resident and infiltrating macrophage function during uveoretinitis.2002
- CD200 and membrane protein interactions in the control of myeloid cellsTrends in Immunology, 2002
- CD200 Immunoadhesin Suppresses Collagen-Induced Arthritis in MiceClinical Immunology, 2001
- Transplant tolerance modifying antibody to CD200 receptor, but not CD200, alters cytokine production profile from stimulated macrophagesEuropean Journal of Immunology, 2001
- Interphotoreceptor Retinoid Binding Protein Peptide-induced Uveitis in B10.RIII Mice: Characterization of Disease Parameters and ImmunomodulationExperimental Eye Research, 2001
- Distribution of OX2 antigen and OX2 receptor within retina.2001
- Putting the brakes on innate immunity: a regulatory role for CD200?Nature Immunology, 2001
- Down-Regulation of the Macrophage Lineage Through Interaction with OX2 (CD200)Science, 2000
- Lymphoid/Neuronal Cell Surface OX2 Glycoprotein Recognizes a Novel Receptor on Macrophages Implicated in the Control of Their FunctionImmunity, 2000
- Identification of a new epitope of human IRBP that induces autoimmune uveoretinitis in mice of the H-2b haplotype.2000